MedPath

Omega-3 in prevention of renal scars in pyelonephritis

Phase 2
Conditions
Pyelonephritis.
Tubulo-interstitial nephritis, not specified as acute or chronic
Registration Number
IRCT2015062922965N1
Lead Sponsor
Vice Chancellor for research of Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Children aged between 1 months and 10 years old with a definite diagnosis of acute pyelonephritis based on clinical; laboratory and 99m Tc-DMSA renal scan finding
Exclusion criteria:Children with neurogenic bladder;systemic hypertension; obstructive uropathy; and high grade vesicoureteral (grade4–5)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of renal Scar. Timepoint: Six months after intervention. Method of measurement: using nuclear scan 99mtc_DMSA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath